MedTrace Logo

Transcranial Doppler Using Wearable Ultrasound Patch

NCT06073145 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2024-04-10

No results posted yet for this study

Summary

The main objective of this research is to measure the Doppler signal by the ultrasonic patch. Blood flow measurement is critical for vasospasm, stroke, and embolism monitoring on patients in the ICU or understanding the neurovascular coupling on different subjects. Currently, A conventional transcranial Doppler (TCD) probe is widely used for these applications. A headset design must be applied and fixed on the participants to obtain stable blood flow spectra. However, the TCD headset is operator dependent. The operator needs to be a trained expert and hold the ultrasound probe to get accurate blood flow velocity information. The stretchable and wearable non-invasive ultrasonic patch can not only free the operator's hands but can also provide long-term continuous monitoring, which is not possible by using the current operator-dependent ultrasound machine. The device can be conformal to the skin and attached to the skin surface.

Conditions

  • Medical Device Complication
  • Brain Injuries
  • Brain Diseases
  • Stroke
  • Vasospasm

Interventions

DEVICE

conventional transcranial Doppler probe and wearable ultrasound patch.

Comparison of the measurements from conventional transcranial Doppler probe and wearable ultrasound patch.

Sponsors & Collaborators

Principal Investigators

  • Sheng Xu, PhD · University of California, San Diego

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-27
Primary Completion
2024-04-02
Completion
2024-04-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06073145 on ClinicalTrials.gov